COGT
Price
$16.00
Change
+$0.57 (+3.69%)
Updated
Oct 15, 11:16 AM (EDT)
Capitalization
2.16B
32 days until earnings call
Intraday Buy/Sell Signals
IDYA
Price
$27.83
Change
+$0.76 (+2.81%)
Updated
Oct 15, 11:16 AM (EDT)
Capitalization
2.37B
26 days until earnings call
Intraday Buy/Sell Signals
Interact to see
Advertisement

COGT vs IDYA

Header iconCOGT vs IDYA Comparison
Open Charts COGT vs IDYABanner chart's image
Cogent Biosciences
Price$16.00
Change+$0.57 (+3.69%)
Volume$100
Capitalization2.16B
IDEAYA Biosciences
Price$27.83
Change+$0.76 (+2.81%)
Volume$227
Capitalization2.37B
COGT vs IDYA Comparison Chart in %
COGT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IDYA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
COGT vs. IDYA commentary
Oct 16, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is COGT is a Hold and IDYA is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 16, 2025
Stock price -- (COGT: $15.44 vs. IDYA: $27.07)
Brand notoriety: COGT and IDYA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: COGT: 84% vs. IDYA: 114%
Market capitalization -- COGT: $2.16B vs. IDYA: $2.37B
COGT [@Biotechnology] is valued at $2.16B. IDYA’s [@Biotechnology] market capitalization is $2.37B. The market cap for tickers in the [@Biotechnology] industry ranges from $105.69B to $0. The average market capitalization across the [@Biotechnology] industry is $2.02B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

COGT’s FA Score shows that 0 FA rating(s) are green whileIDYA’s FA Score has 0 green FA rating(s).

  • COGT’s FA Score: 0 green, 5 red.
  • IDYA’s FA Score: 0 green, 5 red.
According to our system of comparison, IDYA is a better buy in the long-term than COGT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

COGT’s TA Score shows that 5 TA indicator(s) are bullish while IDYA’s TA Score has 4 bullish TA indicator(s).

  • COGT’s TA Score: 5 bullish, 4 bearish.
  • IDYA’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, COGT is a better buy in the short-term than IDYA.

Price Growth

COGT (@Biotechnology) experienced а -0.03% price change this week, while IDYA (@Biotechnology) price change was +0.56% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.44%. For the same industry, the average monthly price growth was +17.42%, and the average quarterly price growth was +81.94%.

Reported Earning Dates

COGT is expected to report earnings on Nov 17, 2025.

IDYA is expected to report earnings on Nov 11, 2025.

Industries' Descriptions

@Biotechnology (+0.44% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IDYA($2.37B) has a higher market cap than COGT($2.16B). COGT YTD gains are higher at: 97.885 vs. IDYA (5.331). COGT has higher annual earnings (EBITDA): -299.34M vs. IDYA (-380.2M). IDYA has more cash in the bank: 670M vs. COGT (238M). IDYA has less debt than COGT: IDYA (26.6M) vs COGT (60.7M). IDYA has higher revenues than COGT: IDYA (7M) vs COGT (0).
COGTIDYACOGT / IDYA
Capitalization2.16B2.37B91%
EBITDA-299.34M-380.2M79%
Gain YTD97.8855.3311,836%
P/E RatioN/AN/A-
Revenue07M-
Total Cash238M670M36%
Total Debt60.7M26.6M228%
FUNDAMENTALS RATINGS
COGT vs IDYA: Fundamental Ratings
COGT
IDYA
OUTLOOK RATING
1..100
1971
VALUATION
overvalued / fair valued / undervalued
1..100
84
Overvalued
57
Fair valued
PROFIT vs RISK RATING
1..100
7569
SMR RATING
1..100
10097
PRICE GROWTH RATING
1..100
3643
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
9050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

IDYA's Valuation (57) in the null industry is in the same range as COGT (84) in the Miscellaneous industry. This means that IDYA’s stock grew similarly to COGT’s over the last 12 months.

IDYA's Profit vs Risk Rating (69) in the null industry is in the same range as COGT (75) in the Miscellaneous industry. This means that IDYA’s stock grew similarly to COGT’s over the last 12 months.

IDYA's SMR Rating (97) in the null industry is in the same range as COGT (100) in the Miscellaneous industry. This means that IDYA’s stock grew similarly to COGT’s over the last 12 months.

COGT's Price Growth Rating (36) in the Miscellaneous industry is in the same range as IDYA (43) in the null industry. This means that COGT’s stock grew similarly to IDYA’s over the last 12 months.

COGT's P/E Growth Rating (100) in the Miscellaneous industry is in the same range as IDYA (100) in the null industry. This means that COGT’s stock grew similarly to IDYA’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
COGTIDYA
RSI
ODDS (%)
Bearish Trend 3 days ago
90%
N/A
Stochastic
ODDS (%)
Bearish Trend 3 days ago
89%
Bullish Trend 3 days ago
79%
Momentum
ODDS (%)
Bullish Trend 3 days ago
82%
Bearish Trend 3 days ago
81%
MACD
ODDS (%)
Bullish Trend 3 days ago
83%
Bearish Trend 3 days ago
69%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
81%
Bullish Trend 3 days ago
77%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
83%
Bullish Trend 3 days ago
81%
Advances
ODDS (%)
Bullish Trend 7 days ago
83%
Bullish Trend 3 days ago
78%
Declines
ODDS (%)
Bearish Trend 3 days ago
83%
Bearish Trend 7 days ago
77%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
82%
Bearish Trend 3 days ago
73%
Aroon
ODDS (%)
Bullish Trend 3 days ago
82%
Bullish Trend 3 days ago
82%
View a ticker or compare two or three
Interact to see
Advertisement
COGT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IDYA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MRSJX26.46N/A
N/A
MFS Research International R4
TGRIX13.92N/A
N/A
American Century International Gr I
PSKCX44.26N/A
N/A
Virtus KAR Mid-Cap Growth C
GRERX10.71N/A
N/A
Goldman Sachs Real Estate Securities R
BRSDX15.01N/A
N/A
MFS Blended Research Small Cap Eq A

COGT and

Correlation & Price change

A.I.dvisor indicates that over the last year, COGT has been loosely correlated with SPHDF. These tickers have moved in lockstep 63% of the time. This A.I.-generated data suggests there is some statistical probability that if COGT jumps, then SPHDF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To COGT
1D Price
Change %
COGT100%
-4.72%
SPHDF - COGT
63%
Loosely correlated
N/A
NUVL - COGT
51%
Loosely correlated
-5.66%
ATXS - COGT
50%
Loosely correlated
+37.66%
IDYA - COGT
50%
Loosely correlated
+1.12%
CGON - COGT
49%
Loosely correlated
-0.23%
More

IDYA and

Correlation & Price change

A.I.dvisor indicates that over the last year, IDYA has been loosely correlated with IMNM. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if IDYA jumps, then IMNM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IDYA
1D Price
Change %
IDYA100%
+1.12%
IMNM - IDYA
59%
Loosely correlated
-1.26%
NRIX - IDYA
58%
Loosely correlated
-5.61%
NUVL - IDYA
58%
Loosely correlated
-5.66%
CGON - IDYA
57%
Loosely correlated
-0.23%
XENE - IDYA
56%
Loosely correlated
+1.45%
More